What it's really like to live with dementia

by Catherine Bailey Et Al,The ConversationBeing around family and friends is important. Credit: PexelsMore than225,000 people develop dementiaevery year – that's roughly one pers

Updated on: June 11,2024

What it's really like to live with dementia

by Catherine Bailey Et Al,The ConversationBeing around family and friends is important. Credit: PexelsMore than225,000 people develop dementiaevery year – that's roughly one pers

Updated on:June 11,2024

Study unveils a cortico-amygdala neural substrate supporting fear extinction via endocannabinoids

by Ingrid Fadelli , Medical XpressZooming into fear and endocannabinoids in the brain. Credit: Ozge Gunduz-Cinar and Biorender.Endogenous cannabinoids, or endocannabinoids for short, are lipid-based n

Updated on: January 11,2024

Study unveils a cortico-amygdala neural substrate supporting fear extinction via endocannabinoids

by Ingrid Fadelli , Medical XpressZooming into fear and endocannabinoids in the brain. Credit: Ozge Gunduz-Cinar and Biorender.Endogenous cannabinoids, or endocannabinoids for short, are lipid-based n

Updated on:January 11,2024

Physical fitness since childhood associated with cerebellar volume in adolescence: Study

byUniversity of Eastern FinlandPhysical fitness since childhood predicts cerebellar volume in adolescence. Credit: Petri JalankoPhysical fitness since childhood is associated with cerebellar gra

Updated on: January 10,2024

Physical fitness since childhood associated with cerebellar volume in adolescence: Study

byUniversity of Eastern FinlandPhysical fitness since childhood predicts cerebellar volume in adolescence. Credit: Petri JalankoPhysical fitness since childhood is associated with cerebellar gra

Updated on:January 10,2024

Preparing for a tough exam? A tough gym workout could help with your studies

Updated on: December 08,2025

Preparing for a tough exam? A tough gym workout could help with your studies

Updated on:December 08,2025

S1P transporter could be crucial in the development of therapeutics for the treatment of multiple sclerosis

by National University of SingaporeSpns2 deletion affects lymphocyte confinement and the vascular structures of the lymph nodes. A Representative confocal images of T cell zone (CD3-green) and B

Updated on: April 22,2024

S1P transporter could be crucial in the development of therapeutics for the treatment of multiple sclerosis

by National University of SingaporeSpns2 deletion affects lymphocyte confinement and the vascular structures of the lymph nodes. A Representative confocal images of T cell zone (CD3-green) and B

Updated on:April 22,2024

FDA approves Vyalev for advanced Parkinson's disease

by Lori SolomonThe U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Vyalev is the first an

Updated on: November 07,2024

FDA approves Vyalev for advanced Parkinson's disease

by Lori SolomonThe U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Vyalev is the first an

Updated on:November 07,2024

Alzheimer's test provides much needed answers to patients and their families

by Brain Canada FoundationCredit: Pixabay/CC0 Public DomainOver half a million Canadians are currently living with Alzheimer's disease or a related form of dementia, and with a rapidly aging popul

Updated on: April 18,2024

Alzheimer's test provides much needed answers to patients and their families

by Brain Canada FoundationCredit: Pixabay/CC0 Public DomainOver half a million Canadians are currently living with Alzheimer's disease or a related form of dementia, and with a rapidly aging popul

Updated on:April 18,2024

Insights on FDA's controversial approval of Alzheimer's drug

by Patrick Ercolano,Johns Hopkins UniversitySupriya Munshaw. Credit: Johns Hopkins UniversityThe U.S. Food and Drug Administration's recent approval of aducanumab, a treatment for Alzheimer&

Updated on: May 22,2024

Insights on FDA's controversial approval of Alzheimer's drug

by Patrick Ercolano,Johns Hopkins UniversitySupriya Munshaw. Credit: Johns Hopkins UniversityThe U.S. Food and Drug Administration's recent approval of aducanumab, a treatment for Alzheimer&

Updated on:May 22,2024

Research implicates calcium in 'chemobrain,' pointing the way toward potential therapy

byColumbia University Irving Medical CenterPreventing chemobrain. A leak of calcium through the ryanodine receptor (above) in the brain led to neurocognitive dysfunction in mice treated with a c

Updated on: January 11,2024

Research implicates calcium in 'chemobrain,' pointing the way toward potential therapy

byColumbia University Irving Medical CenterPreventing chemobrain. A leak of calcium through the ryanodine receptor (above) in the brain led to neurocognitive dysfunction in mice treated with a c

Updated on:January 11,2024

A devastating nerve disease stalks a mountain village

Updated on: December 30,2024

A devastating nerve disease stalks a mountain village

Updated on:December 30,2024

Discovery of how blood clots harm brain and body in COVID-19 points to new therapy

byGladstone InstitutesFibrin (red) and toxic microglia (green) in the brain of a mouse infected with COVID-19. Credit: Jae Kyu Ryu and Katerina Akassoglou of Gladstone InstitutesIn a study that

Updated on: September 04,2024

Discovery of how blood clots harm brain and body in COVID-19 points to new therapy

byGladstone InstitutesFibrin (red) and toxic microglia (green) in the brain of a mouse infected with COVID-19. Credit: Jae Kyu Ryu and Katerina Akassoglou of Gladstone InstitutesIn a study that

Updated on:September 04,2024

High levels of HDL cholesterol tied to higher dementia risk

by Lori SolomonElevated levels of high-density lipoprotein cholesterol (HDL-C) are associated with an increased risk for all-cause dementia, according to a study published online Nov. 29 inThe L

Updated on: February 24,2024

High levels of HDL cholesterol tied to higher dementia risk

by Lori SolomonElevated levels of high-density lipoprotein cholesterol (HDL-C) are associated with an increased risk for all-cause dementia, according to a study published online Nov. 29 inThe L

Updated on:February 24,2024